DoD Tuberous Sclerosis Complex Pilot Clinical Trial Award

Funding Opportunity Number: W81XWH-15-TSCRP-PCTA Opportunity Category: DiscretionaryFunding Instrument Type: Cooperative AgreementGrantCategory of Funding Activity: Science and Technology and other Research and DevelopmentCFDA Number: 12.420Eligible Applicants Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled "Additional Information on Eligibility"Agency Name: DOD-AMRAAClosing Date: Jul 27, 2015Award Ceiling: Expected Number of Awards: 2Creation Date: May 06, 2015Funding Opportunity Description: The PCTA mechanism supports exploratory studies involving limited human exposure that produce diagnostic or therapeutic information, safety, and tolerability studies and studies to determine the mechanism of action. These studies should be aimed at obtaining preliminary data leading to the development of interventions, as well as clinical biomarkers, with the potential to improve TSC outcomes. Preclinical studies will not be supported by this mechanism. Examples of acceptable studies include but are not limited to the following: • Identification of an appropriate population for the proposed study. • Identification of the dosage, duration, and/or delivery strategy of an intervention. • Evaluation of the feasibility of the intervention in TSC. • Development of clinical biomarkers or outcome measures for future clinical trials. • Evaluation of efficacy and safety. If the cli...
Source: Grants.gov - Category: Research Tags: Science and Technology and other Research and Development Source Type: funding